WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
ICLR
ICON PLC
$309.44$137.85124.47%37.28x21.24x3.10x2.71x1.17x$1.17B4.58%$9.43B114.23$28.83B17.79
FONR
FONAR CORP
$16.19N/AN/A8.57xN/A1.02x0.66xN/A$12.25M11.75%$163.89M25.46$91.25M3.54
IDXX
IDEXX LABORATORIES INC
$494.26$90.63445.36%48.60x44.57x11.21x27.66x4.97x$772.88M1.88%$1.48B17.87$41.66B34.21
STRR
STAR EQUITY HOLDINGS INC
$0.87$22.88-96.22%0.54xN/A0.30x0.21x0.02x$3.23M23.93%$65.30M4.18-$1.63M-0.06
RVTY
REVVITY INC
$102.68$68.8549.14%18.47x14.86x4.61x1.61x0.94x$9.90M0.08%$7.87B63.73$15.80B12.68
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$239.43$189.5826.30%25.83x16.50x2.97x3.42x0.60x$365.37M2.98%$3.60B70.22$15.08B14.70
MEDP
MEDPACE HOLDINGS INC
$397.56$56.17607.80%39.09x54.46x6.25x18.34x397.95x$473.34M3.86%$671.54M21.77$12.05B29.68
NEOG
NEOGEN CORP
$12.37$3.43260.85%618.50x19.63x2.88x0.85x1.30x-$12.98M-0.49%$3.15B14.53$3.41B18.06
TMO
THERMO FISHER SCIENTIFIC INC
$577.39$367.7157.02%37.20x21.32x5.20x4.71x0.72x$7.01B3.15%$46.74B121.08$247.01B22.33
QGEN
QIAGEN NV
$41.52$21.5093.13%27.68x16.64x4.82x2.49x1.10x$309.75M3.27%$3.81B16.69$10.32B14.98
ENZ
ENZO BIOCHEM INC
$1.06$23.75-95.54%1.58xN/A4.17x0.77x0.02x-$45.92M-85.75%$70.78M1.40$1.16M0.03
A
AGILENT TECHNOLOGIES INC
$137.49$70.9693.76%32.58x22.88x5.98x6.51x1.01x$1.65B4.09%$6.19B21.12$41.10B24.32
SHC
SOTERA HEALTH CO
$11.27$30.76-63.36%62.61x9.16x3.02x7.18x0.13x-$362.71M-11.46%$443.73M1.58$5.21B12.81
DGX
QUEST DIAGNOSTICS INC
$137.55$80.4071.08%18.27x15.60x1.64x2.38x1.23x$947.00M6.20%$6.43B57.95$20.16B11.84
LH
LABORATORY CORP OF AMERICA HOLDINGS
$207.94$226.09-8.03%43.32x10.41x1.44x2.22x0.36x$874.10M5.00%$7.88B93.64$22.91B14.76
CSTL
CASTLE BIOSCIENCES INC
$19.86N/AN/A-9.28x-9.15x2.42x1.39xN/A-$19.23M-3.62%$391.27M14.60$461.63M-10.25
DHR
DANAHER CORP
$250.41$151.7465.02%42.02x21.46x8.24x3.47x0.74x$5.57B3.00%$53.44B72.16$196.61B26.08
TWST
TWIST BIOSCIENCE CORP
$30.75N/AN/A-8.52x-8.22x6.74x3.01xN/A-$128.84M-7.29%$590.04M10.26$1.60B-9.44
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,235.37$534.83130.99%34.22x25.54x7.12x-176.97x1.28x$861.39M3.19%-$149.94M-6.86$28.55B24.35
WAT
WATERS CORP
$310.25$161.4192.21%28.54x21.28x6.20x15.97x1.07x$442.18M2.41%$1.15B19.47$20.41B20.39
SERA
SERA PROGNOSTICS INC
$10.04N/AN/A-8.66xN/A1,004.00x4.64xN/A-$27.01M-8.63%$70.16M2.25$322.95M-9.29
IQV
IQVIA HOLDINGS INC
$240.84$118.60103.06%32.59x19.84x2.95x7.15x1.08x$1.50B3.39%$6.11B33.25$56.23B17.27
XGN
EXAGEN INC
$1.38N/AN/A-1.03x-1.02x0.46x1.05xN/A-$15.27M-62.54%$22.69M1.28$10.52M-0.58
PSNL
PERSONALIS INC
$1.30N/AN/A-0.58x-0.59x0.85x0.51xN/A-$67.17M-107.23%$129.44M2.69$46.99M-0.49
NTRA
NATERA INC
$91.50N/AN/A-24.21x-29.05x9.72x14.44xN/A-$286.15M-2.72%$765.33M6.66$10.84B-28.28
EXAS
EXACT SCIENCES CORP
$63.24N/AN/A-55.96x-27.98x4.56x3.65xN/A$31.93M0.28%$3.15B17.46$13.43B257.27
PRPO
PRECIPIO INC
$5.86N/AN/A-1.30xN/A0.50x0.58xN/A-$3.69M-48.45%$14.43M11.12$8.00M-1.85
DRIO
DARIOHEALTH CORP
$1.50N/AN/A-0.78x-0.77x2.09x0.76xN/A-$30.96M-72.73%$58.14M2.05$36.91M-0.68
OLK
OLINK HOLDING AB (PUBL)
$22.43N/AN/A-89.72x448.60x16.44x5.55xN/A-$48.97M-1.76%$502.70M4.04$2.69B-134.43
ACRS
ACLARIS THERAPEUTICS INC
$1.17N/AN/A-0.92x-0.74x2.61x0.53xN/A-$79.63M-97.52%$157.18M2.25$43.53M-0.49
NEO
NEOGENOMICS INC
$14.03N/AN/A-20.04x-28.06x2.98x1.90xN/A-$30.71M-1.75%$941.54M7.50$2.06B-246.01
STIM
NEURONETICS INC
$3.75N/AN/A-3.57x-4.36x1.51x3.26xN/A-$34.41M-32.03%$34.19M1.19$114.38M-5.03
DMTK
DERMTECH INC
$0.61N/AN/A-0.20x-0.19x1.31x0.37xN/A-$77.88M-388.60%$57.18M1.75$35.44M-0.37
GH
GUARDANT HEALTH INC
$18.10N/AN/A-4.23x-3.58x3.59x13.88xN/A-$345.46M-17.04%$158.68M1.42$2.40B-5.53
OCX
ONCOCYTE CORP
$2.46N/AN/A-0.66x0.88x12.55x0.99xN/A-$23.25M-123.54%$20.47M2.68$12.09M-0.46
FLGT
FULGENT GENETICS INC
$20.74N/AN/A-3.68x-26.94x2.14x0.54xN/A$5.57M0.90%$1.14B38.15$521.45M-3.89
BNR
BURNING ROCK BIOTECH LTD
$0.82N/AN/A-0.93x-1.08x1.13x0.79xN/A-$35.53M-42.27%$106.72M1.04$332.29kN/A
BGLC
BIONEXUS GENE LAB CORP
$0.60N/AN/A-3.25xN/A0.97x1.09xN/A-$1.45M-15.29%$9.66M0.61$8.03M-3.23
RDNT
RADNET INC
$48.67$13.88250.57%973.40x91.83x1.91x5.28x1.25x$44.35M1.43%$630.70M9.92$4.48B16.88
LAB
STANDARD BIOTOOLS INC
$2.42N/AN/A-2.57xN/A1.80x-4.74xN/A-$46.12M-24.09%-$148.05M-1.87$748.59M-11.40
APDN
APPLIED DNA SCIENCES INC
$0.24N/AN/A-0.43x0.00x0.36x0.96xN/A-$7.67M-234.73%$4.23M0.31$1.07M-0.18
PRE
PRENETICS GLOBAL LTD
$4.79N/AN/A-0.86x-7.98x2.48x0.28xN/AN/AN/A$206.36M18.35$14.69MN/A
XWEL
XWELL INC
$1.80N/AN/A-0.27xN/A0.25x0.58xN/A-$17.98M-239.22%$13.00M3.11$9.44M-0.39
MDXH
MDXHEALTH SA
$2.49N/AN/A-0.15x-1.96x0.10x0.93xN/A-$24.24M-360.12%$7.21M2.67$91.77M-4.48
CDNA
CAREDX INC
$7.98N/AN/A-2.25x-15.06x1.53x1.58xN/A-$26.73M-6.23%$261.33M4.86$358.69M-1.97
BDSX
BIODESIX INC
$1.26N/AN/A-1.97x-2.74x2.11x26.67xN/A-$45.93M-44.37%$4.58M0.06$156.55M-4.22
NDRA
ENDRA LIFE SCIENCES INC
$0.26N/AN/A-0.16xN/AN/A0.51xN/A-$9.57M-578.46%$5.66M0.89$429.77k-0.04
CHEK
CHECK-CAP LTD
$2.22N/AN/A-0.74x-0.93xN/A0.47xN/A-$17.74M-136.58%$27.40M4.68$9.50M-0.50
ME
23ANDME HOLDING CO
$0.47N/AN/A-0.42xN/A0.91x0.60xN/A-$194.26M-86.51%$377.19M0.78$60.53M-0.12
ULS
UL SOLUTIONS INC
$33.95N/AN/A26.12xN/A2.54xN/AN/A$252.00M3.71%$654.00M3.27N/AN/A
PRPH
PROPHASE LABS INC
$5.06N/AN/A-5.16x6.49x1.96x1.85xN/A-$14.46M-16.60%$49.38M2.87$110.54M-7.46
AWH
ASPIRA WOMEN's HEALTH INC
$3.40N/AN/A-1.88x-0.55x3.43x-17.75xN/A-$15.92M-50.71%-$2.37M-0.26$41.97M-2.54
OPK
OPKO HEALTH INC
$1.23N/AN/A-4.92x-10.25x1.07x0.62xN/A-$41.76M-4.55%$1.39B1.85$1.07B-16.31
NOTV
INOTIV INC
$4.67N/AN/A-3.59xN/A0.21x0.47xN/A$6.48M5.37%$254.16M9.87$526.96M8.85
VNRX
VOLITIONRX LTD
$0.80N/AN/A-1.60xN/A72.73x-8.41xN/A-$19.15M-33.63%-$7.80M-0.11$50.78M-1.51
MYGN
MYRIAD GENETICS INC
$18.63N/AN/A-5.86xN/A2.05x2.14xN/A-$184.20M-11.94%$783.20M9.46$1.69B-9.10
ISPC
ISPECIMEN INC
$0.28N/AN/A-0.23xN/A0.25x0.26xN/A-$10.55M-419.78%$9.74M1.08$378.89k-0.04
GENE
GENETIC TECHNOLOGIES LTD
$2.25N/AN/A-0.76xN/A0.08x0.17xN/A-$5.00M-1,154.58%$3.15M16.35-$1.67MN/A
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.45N/AN/A-2.69xN/A8.45x5.81xN/A-$6.06M-28.29%$4.86M0.56$26.97M-3.53
PMD
PSYCHEMEDICS CORP
$2.65N/AN/A-3.67xN/A0.69x2.28xN/A-$1.64M-10.78%$6.67M1.16$15.52M-20.21
ILMN
ILLUMINA INC
$122.87N/AN/A-16.74x21.15x4.31x3.40xN/A$283.00M1.46%$5.75B36.36$20.65B-33.97
MYNZ
MAINZ BIOMED NV
$0.90N/AN/A-0.55xN/A16.35x5.86xN/A-$23.84M-163.29%$3.25M0.20$18.35M-0.75
TRIB
TRINITY BIOTECH PLC
$1.83N/AN/AN/AN/A0.25x-0.59xN/AN/AN/A-$23.95M-3.12$65.20MN/A
MMA
ALTA GLOBAL GROUP LTD
$3.10N/AN/A-0.59xN/A20.67xN/AN/A-$5.92M-18.68%-$69.50M-6.80N/AN/A
CNTG
CENTOGENE NV
$0.46N/AN/A-0.29xN/A0.23x-0.77xN/A-$28.26M-222.13%-$16.55M-0.60$62.45M-1.41
TTOO
T2 BIOSYSTEMS INC
$2.76N/AN/A-0.14xN/A1.00x-0.54xN/A-$48.33M-670.91%-$28.04M-10.74$48.47M-1.14

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 50, which is 22 points higher than the diagnostic & research industry average of 28. It passed 16 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 49.87% over the past year, overperforming other diagnostic & research stocks by 55 percentage points.

Icon has an average 1 year price target of $346.43, an upside of 11.95% from Icon's current stock price of $309.44.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Icon, 71.43% have issued a Strong Buy rating, 28.57% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the second best diagnostic & research stock with a Zen Score of 47, which is 19 points higher than the diagnostic & research industry average of 28. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 3.45% over the past year, overperforming other diagnostic & research stocks by 9 percentage points.

3. Idexx Laboratories (NASDAQ:IDXX)


Idexx Laboratories (NASDAQ:IDXX) is the third best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 15 out of 33 due diligence checks and has strong fundamentals. Idexx Laboratories has seen its stock lose -1.86% over the past year, overperforming other diagnostic & research stocks by 3 percentage points.

Idexx Laboratories has an average 1 year price target of $584.00, an upside of 18.16% from Idexx Laboratories's current stock price of $494.26.

Idexx Laboratories stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Idexx Laboratories, 60% have issued a Strong Buy rating, 0% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 3.08%, which is 2 percentage points higher than the diagnostic & research industry average of 1.35%.

Qiagen Nv's dividend payout ratio of 85.3% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.09%, which is 1 percentage points higher than the diagnostic & research industry average of 1.35%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.39%, which is the same as the diagnostic & research industry average of 1.35%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 60% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.33% in the last day, and up 3.77% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Icon has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Icon's stock has gained 49.87% in the past year. It has overperformed other stocks in the diagnostic & research industry by 55 percentage points.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 8.13% in the past year. It has overperformed other stocks in the diagnostic & research industry by 13 percentage points.

3. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -58.27% in the past year. It has underperformed other stocks in the diagnostic & research industry by -53 percentage points.

Are diagnostic & research stocks a good buy now?

48.94% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 9.65% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.76x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.